Mitsubishi Chemical Divests 105,000-Tonne Taiwan MMA Business to CPDC, Accelerating Asian Market Reorganization and High-Growth Sector Focus

August 9, 2026

echemi Japan

Overview

Mitsubishi Chemical divested its 60% stake in Kaohsiung Monomer Co. (MMA production) in Taiwan to China Petrochemical Development Corporation (CPDC) by August 3, 2026. This strategic decision accelerates the reorganization of its MMA (methyl methacrylate) business in Asia, aiming to concentrate production in more competitive locations and redirect resources to high-growth markets. This move will allow the company to intensify investments in strategic areas like high-performance materials and healthcare.

In Depth

Key Findings

Mitsubishi Chemical has divested its 60% stake in Kaohsiung Monomer Co., an MMA (methyl methacrylate) production business in Taiwan, to China Petrochemical Development Corporation (CPDC) by August 3, 2026. This sale represents a fundamental restructuring of the company’s MMA operations in Asia, a strategic move designed to consolidate production in more competitive regions and accelerate the allocation of management resources towards high-growth sectors.

Technical / Clinical Details

Kaohsiung Monomer Co. operates a plant in Taiwan with an annual MMA production capacity of 105,000 tonnes. MMA is a primary raw material for acrylic resins (PMMA), widely used in diverse applications such as automotive parts, building materials, optical lenses, and displays. Through this divestment, Mitsubishi Chemical aims to optimize its MMA production system in the Asia-Pacific region, specifically addressing intensified competition in vast markets like China. Post-divestment, the company will continue its MMA business through existing sites in Japan, Thailand, and Saudi Arabia, but with a focus on building a more efficient and sustainable supply chain.

Background & Context

In recent years, the Asian MMA market has seen a surge in new large-scale production capacity expansions by Chinese companies, leading to oversupply and intensified price competition. To counter these market shifts, Mitsubishi Chemical recognized the necessity of accelerating its strategy of selection and concentration. As part of its mid-to-long-term growth strategy, the company is bolstering investments in areas such as life sciences, high-performance materials, and carbon-neutral solutions. In more commoditized product sectors like MMA, it is pursuing portfolio optimization through structural reforms to maintain competitiveness.

Strategic Significance & Outlook

This divestment of the Taiwan MMA business marks a critical milestone for Mitsubishi Chemical as it progresses its portfolio transformation within the global chemical industry. The move will allow the company to further accelerate investments in strategic growth areas such as high-performance materials and healthcare, aiming for a business structure with higher profitability and sustainability. For CPDC, this translates into strengthened MMA production capacity and expanded influence in the Asian market. This development symbolizes a structural shift in the Asian chemical market and may prompt similar portfolio reviews among other chemical companies.

Source: https://www.echemi.com/cms/3168802.html

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.